Harmony Biosciences Holdings (HRMY) Change in Inventory (2019 - 2026)
Harmony Biosciences Holdings (HRMY) reported Change in Inventory of -$76000.0 for Q1 2026, up 90.66% on a YoY basis from -$39860.8 in Q1 2025, and up 95.02% sequentially from -$1.5 million in Q4 2025.
Harmony Biosciences Holdings (HRMY) Change in Inventory (2019 - 2026) Analysis & Trends
Harmony Biosciences Holdings (HRMY) has 8 years of Change in Inventory data on file, last reported at -$76000.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Inventory rose 90.66% year-over-year to -$76000.0; the trailing twelve-month figure through Mar 2026 stood at -$1.1 million (down 309.3% YoY), and the FY2025 full-year result was -$1.8 million, down 200.33% from the prior year.
- Change in Inventory climbed to -$76000.0 in Q1 2026, from -$1.5 million in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $1.3 million in Q3 2024 to a low of -$1.5 million in Q4 2025.
- A 5-year average of $49941.2 and a median of $165000.0 in 2022 frame the typical range for Change in Inventory.
- Across the five-year window, Change in Inventory soared 445.92% in 2024 and plunged 638.87% in 2025, its largest moves.
- Tracing HRMY's Change in Inventory over 5 years: stood at $397000.0 in 2022, then tumbled by 30.48% to $276000.0 in 2023, then advanced by 2.54% to $283000.0 in 2024, then sank by 638.87% to -$1.5 million in 2025, then soared by 95.02% to -$76000.0 in 2026.
- Business Quant data shows HRMY's Change in Inventory at -$76000.0 in Q1 2026, -$1.5 million in Q4 2025, and $782000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 71.84 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 97.70 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -26.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Harmony Biosciences Holdings | 2.07 Bn | 1.55 Bn | 170.88 Mn | -76,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -76,000.00 |
| Mar 31, 2026 | -76,000.00 |
| Dec 31, 2025 | -1.53 Mn |
| Dec 31, 2025 | -1.53 Mn |
| Sep 30, 2025 | 782,000.00 |
| Sep 30, 2025 | 782,000.00 |
| Jun 30, 2025 | -284,000.00 |
| Jun 30, 2025 | -284,000.00 |
| Mar 31, 2025 | -814,000.00 |
| Mar 31, 2025 | -814,000.00 |
| Dec 31, 2024 | 283,000.00 |
| Dec 31, 2024 | 283,000.00 |
| Sep 30, 2024 | 1.27 Mn |
| Sep 30, 2024 | 1.27 Mn |
| Jun 30, 2024 | -214,000.00 |
| Jun 30, 2024 | -214,000.00 |
| Mar 31, 2024 | 494,000.00 |
| Mar 31, 2024 | 494,000.00 |
| Dec 31, 2023 | 276,000.00 |
| Dec 31, 2023 | 276,000.00 |